Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Chattanooga, Tennessee Clinical Trials

A listing of Chattanooga, Tennessee clinical trials actively recruiting patient volunteers.

RESULTS

Found (7) clinical trials

Study to Evaluate the Pharmacokinetics Pharmacodynamics and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease

This study will be conducted to assess the pharmacokinetics of vadadustat 600, 750, and 900 milligrams daily, and intravenous erythropoiesis-stimulating agent (darbepoetin alfa or epoetin alfa), in hemodialysis participants with anemia associated with chronic kidney disease.

Phase

1.14 miles

Learn More »

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

This study compares the effect of two doses of semaglutide (1.0 mg and 2.0 mg) in people with type 2 diabetes (T2D). People taking part in the study will take the medicine together with their current diabetes medicine (sulphonylurea and/or metformin). Participants will get a dose of either 1.0 mg ...

Phase

2.36 miles

Learn More »

A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain.

This is a prospective, randomized, double-blind, placebo-controlled study to demonstrate the efficacy and safety of linzagolix administered orally once daily at doses of 75 mg alone and 200 mg in combination with low dose ABT (E2 1 mg/NETA 0.5 mg) versus placebo in the management of moderate to severe EAP ...

Phase

2.36 miles

Learn More »

A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Participants will either get semaglutide tablets or placebo tablets ("dummy" medicine) - which treatment is decided by chance. Participants must take one tablet with water every morning on ...

Phase

4.38 miles

Learn More »

A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD

The study will be performed in patients with Nonalcoholic Fatty Liver Disease. The primary endpoint will be the assessment of the change in the percentage of liver fat mass (assessed by MRI-PDFF).

Phase

4.38 miles

Learn More »

A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

The researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in people with type 2 diabetes. Participants will get semaglutide (active medicine) or placebo ('dummy medicine'). This is known as participants' study medicine - which treatment participants get is ...

Phase

4.38 miles

Learn More »

Effective treatment of C. diff infections is critical, but how do we prevent the problem of recurrences? Recurrence of Clostridium difficile infection (CDI) is a key unmet medical need in the management of CDI: Occurs in up to 30% of patients following initial therapy Significant burden on patients due to ...

Phase N/A

9.38 miles

Learn More »